0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Swine Reproductive and Respiratory Syndrome Vaccine Market Research Report 2026
Published Date: 2026-02-27
|
Report Code: QYRE-Auto-12G9085
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global Swine Reproductive and Respiratory Syndrome Vaccine Market Outlook 2022
BUY CHAPTERS

Global Swine Reproductive and Respiratory Syndrome Vaccine Market Research Report 2026

Code: QYRE-Auto-12G9085
Report
2026-02-27
Pages:129
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Swine Reproductive and Respiratory Syndrome Vaccine Market Size

The global Swine Reproductive and Respiratory Syndrome Vaccine market was valued at US$ 562 million in 2025 and is anticipated to reach US$ 1099 million by 2032, at a CAGR of 10.2% from 2026 to 2032.

Swine Reproductive and Respiratory Syndrome Vaccine Market

Swine Reproductive and Respiratory Syndrome Vaccine Market

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Swine Reproductive and Respiratory Syndrome Vaccine competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Swine reproductive and respiratory syndrome is an acute and highly contagious viral infection characterized by reproductive disorder and respiratory symptoms in pig population.
Boehringer ingelheim is the company with the largest market share, about 25 percent.
This report delivers a comprehensive overview of the global Swine Reproductive and Respiratory Syndrome Vaccine market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Swine Reproductive and Respiratory Syndrome Vaccine. The Swine Reproductive and Respiratory Syndrome Vaccine market size, estimates, and forecasts are provided in terms of sales volume (K Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Swine Reproductive and Respiratory Syndrome Vaccine market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Swine Reproductive and Respiratory Syndrome Vaccine manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Swine Reproductive and Respiratory Syndrome Vaccine Market Report

Report Metric Details
Report Name Swine Reproductive and Respiratory Syndrome Vaccine Market
Accounted market size in 2025 US$ 562 million
Forecasted market size in 2032 US$ 1099 million
CAGR 10.2%
Base Year 2025
Forecasted years 2026 - 2032
Segment by Type
  • Active Vaccine
  • Inactivated Vaccines
by Application
  • Government Tender
  • Market Sales
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company ASCENT CORPORATION, Boehringer-Ingelheim, MSD Animal Health, SPAH, Ceva, Chengdu TECH-BANK Biological Products Co,.Ltd, ringpu, QILU ANIMAL HEALTH PRODUCTS CO.,LTD, DAHUANONG, CAVAC, Komipharm, Agrovet, Bioveta, JINYU BIO-TECNOLOGY CO.,LTD, Phibro Animal Health, ANHUI TIANKANG(GROUP)SHRES O., LTD, Zoetis, WINSUN BIO, PULIKE BIOLOGICAL ENGINERING,INC.
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Provides a detailed analysis of the competitive landscape for Swine Reproductive and Respiratory Syndrome Vaccine manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
  • Chapter 3: Examines Swine Reproductive and Respiratory Syndrome Vaccine sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
  • Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
  • Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
  • Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
  • Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
  • Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

How fast is Swine Reproductive and Respiratory Syndrome Vaccine Market growing?

Ans: The Swine Reproductive and Respiratory Syndrome Vaccine Market witnessing a CAGR of 10.2% during the forecast period 2026-2032.

What is the Swine Reproductive and Respiratory Syndrome Vaccine Market size in 2032?

Ans: The Swine Reproductive and Respiratory Syndrome Vaccine Market size in 2032 will be US$ 1099 million.

Who are the main players in the Swine Reproductive and Respiratory Syndrome Vaccine Market report?

Ans: The main players in the Swine Reproductive and Respiratory Syndrome Vaccine Market are ASCENT CORPORATION, Boehringer-Ingelheim, MSD Animal Health, SPAH, Ceva, Chengdu TECH-BANK Biological Products Co,.Ltd, ringpu, QILU ANIMAL HEALTH PRODUCTS CO.,LTD, DAHUANONG, CAVAC, Komipharm, Agrovet, Bioveta, JINYU BIO-TECNOLOGY CO.,LTD, Phibro Animal Health, ANHUI TIANKANG(GROUP)SHRES O., LTD, Zoetis, WINSUN BIO, PULIKE BIOLOGICAL ENGINERING,INC.

What are the Application segmentation covered in the Swine Reproductive and Respiratory Syndrome Vaccine Market report?

Ans: The Applications covered in the Swine Reproductive and Respiratory Syndrome Vaccine Market report are Government Tender, Market Sales

What are the Type segmentation covered in the Swine Reproductive and Respiratory Syndrome Vaccine Market report?

Ans: The Types covered in the Swine Reproductive and Respiratory Syndrome Vaccine Market report are Active Vaccine, Inactivated Vaccines

1 Swine Reproductive and Respiratory Syndrome Vaccine Market Overview
1.1 Product Definition
1.2 Swine Reproductive and Respiratory Syndrome Vaccine by Type
1.2.1 Global Swine Reproductive and Respiratory Syndrome Vaccine Market Value by Type: 2025 vs 2032
1.2.2 Active Vaccine
1.2.3 Inactivated Vaccines
1.3 Swine Reproductive and Respiratory Syndrome Vaccine by Application
1.3.1 Global Swine Reproductive and Respiratory Syndrome Vaccine Market Value by Application: 2025 vs 2032
1.3.2 Government Tender
1.3.3 Market Sales
1.4 Global Swine Reproductive and Respiratory Syndrome Vaccine Market Size Estimates and Forecasts
1.4.1 Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue 2021–2032
1.4.2 Global Swine Reproductive and Respiratory Syndrome Vaccine Sales 2021–2032
1.4.3 Global Swine Reproductive and Respiratory Syndrome Vaccine Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Swine Reproductive and Respiratory Syndrome Vaccine Market Competition by Manufacturers
2.1 Global Swine Reproductive and Respiratory Syndrome Vaccine Sales Market Share by Manufacturers (2021–2026)
2.2 Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Swine Reproductive and Respiratory Syndrome Vaccine Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Swine Reproductive and Respiratory Syndrome Vaccine, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Swine Reproductive and Respiratory Syndrome Vaccine, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Swine Reproductive and Respiratory Syndrome Vaccine, Product Types and Applications
2.7 Global Key Manufacturers of Swine Reproductive and Respiratory Syndrome Vaccine, Date of Entry into the Industry
2.8 Global Swine Reproductive and Respiratory Syndrome Vaccine Market Competitive Situation and Trends
2.8.1 Global Swine Reproductive and Respiratory Syndrome Vaccine Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Swine Reproductive and Respiratory Syndrome Vaccine Players Market Share by Revenue
2.8.3 Global Swine Reproductive and Respiratory Syndrome Vaccine Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Swine Reproductive and Respiratory Syndrome Vaccine Market Scenario by Region
3.1 Global Swine Reproductive and Respiratory Syndrome Vaccine Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Swine Reproductive and Respiratory Syndrome Vaccine Sales by Region: 2021–2032
3.2.1 Global Swine Reproductive and Respiratory Syndrome Vaccine Sales by Region: 2021–2026
3.2.2 Global Swine Reproductive and Respiratory Syndrome Vaccine Sales by Region: 2027–2032
3.3 Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue by Region: 2021–2032
3.3.1 Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue by Region: 2021–2026
3.3.2 Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue by Region: 2027–2032
3.4 North America Swine Reproductive and Respiratory Syndrome Vaccine Market Facts & Figures by Country
3.4.1 North America Swine Reproductive and Respiratory Syndrome Vaccine Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Swine Reproductive and Respiratory Syndrome Vaccine Sales by Country (2021–2032)
3.4.3 North America Swine Reproductive and Respiratory Syndrome Vaccine Revenue by Country (2021–2032)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Swine Reproductive and Respiratory Syndrome Vaccine Market Facts & Figures by Country
3.5.1 Europe Swine Reproductive and Respiratory Syndrome Vaccine Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Swine Reproductive and Respiratory Syndrome Vaccine Sales by Country (2021–2032)
3.5.3 Europe Swine Reproductive and Respiratory Syndrome Vaccine Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Swine Reproductive and Respiratory Syndrome Vaccine Market Facts & Figures by Region
3.6.1 Asia Pacific Swine Reproductive and Respiratory Syndrome Vaccine Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Swine Reproductive and Respiratory Syndrome Vaccine Sales by Region (2021–2032)
3.6.3 Asia Pacific Swine Reproductive and Respiratory Syndrome Vaccine Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Swine Reproductive and Respiratory Syndrome Vaccine Market Facts & Figures by Country
3.7.1 Latin America Swine Reproductive and Respiratory Syndrome Vaccine Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Swine Reproductive and Respiratory Syndrome Vaccine Sales by Country (2021–2032)
3.7.3 Latin America Swine Reproductive and Respiratory Syndrome Vaccine Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Swine Reproductive and Respiratory Syndrome Vaccine Market Facts & Figures by Country
3.8.1 Middle East and Africa Swine Reproductive and Respiratory Syndrome Vaccine Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Swine Reproductive and Respiratory Syndrome Vaccine Sales by Country (2021–2032)
3.8.3 Middle East and Africa Swine Reproductive and Respiratory Syndrome Vaccine Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Swine Reproductive and Respiratory Syndrome Vaccine Sales by Type (2021–2032)
4.1.1 Global Swine Reproductive and Respiratory Syndrome Vaccine Sales by Type (2021–2026)
4.1.2 Global Swine Reproductive and Respiratory Syndrome Vaccine Sales by Type (2027–2032)
4.1.3 Global Swine Reproductive and Respiratory Syndrome Vaccine Sales Market Share by Type (2021–2032)
4.2 Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue by Type (2021–2032)
4.2.1 Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue by Type (2021–2026)
4.2.2 Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue by Type (2027–2032)
4.2.3 Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue Market Share by Type (2021–2032)
4.3 Global Swine Reproductive and Respiratory Syndrome Vaccine Price by Type (2021–2032)
5 Segment by Application
5.1 Global Swine Reproductive and Respiratory Syndrome Vaccine Sales by Application (2021–2032)
5.1.1 Global Swine Reproductive and Respiratory Syndrome Vaccine Sales by Application (2021–2026)
5.1.2 Global Swine Reproductive and Respiratory Syndrome Vaccine Sales by Application (2027–2032)
5.1.3 Global Swine Reproductive and Respiratory Syndrome Vaccine Sales Market Share by Application (2021–2032)
5.2 Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue by Application (2021–2032)
5.2.1 Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue by Application (2021–2026)
5.2.2 Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue by Application (2027–2032)
5.2.3 Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue Market Share by Application (2021–2032)
5.3 Global Swine Reproductive and Respiratory Syndrome Vaccine Price by Application (2021–2032)
6 Key Companies Profiled
6.1 ASCENT CORPORATION
6.1.1 ASCENT CORPORATION Company Information
6.1.2 ASCENT CORPORATION Description and Business Overview
6.1.3 ASCENT CORPORATION Swine Reproductive and Respiratory Syndrome Vaccine Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 ASCENT CORPORATION Swine Reproductive and Respiratory Syndrome Vaccine Product Portfolio
6.1.5 ASCENT CORPORATION Recent Developments/Updates
6.2 Boehringer-Ingelheim
6.2.1 Boehringer-Ingelheim Company Information
6.2.2 Boehringer-Ingelheim Description and Business Overview
6.2.3 Boehringer-Ingelheim Swine Reproductive and Respiratory Syndrome Vaccine Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Boehringer-Ingelheim Swine Reproductive and Respiratory Syndrome Vaccine Product Portfolio
6.2.5 Boehringer-Ingelheim Recent Developments/Updates
6.3 MSD Animal Health
6.3.1 MSD Animal Health Company Information
6.3.2 MSD Animal Health Description and Business Overview
6.3.3 MSD Animal Health Swine Reproductive and Respiratory Syndrome Vaccine Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 MSD Animal Health Swine Reproductive and Respiratory Syndrome Vaccine Product Portfolio
6.3.5 MSD Animal Health Recent Developments/Updates
6.4 SPAH
6.4.1 SPAH Company Information
6.4.2 SPAH Description and Business Overview
6.4.3 SPAH Swine Reproductive and Respiratory Syndrome Vaccine Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 SPAH Swine Reproductive and Respiratory Syndrome Vaccine Product Portfolio
6.4.5 SPAH Recent Developments/Updates
6.5 Ceva
6.5.1 Ceva Company Information
6.5.2 Ceva Description and Business Overview
6.5.3 Ceva Swine Reproductive and Respiratory Syndrome Vaccine Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Ceva Swine Reproductive and Respiratory Syndrome Vaccine Product Portfolio
6.5.5 Ceva Recent Developments/Updates
6.6 Chengdu TECH-BANK Biological Products Co,.Ltd
6.6.1 Chengdu TECH-BANK Biological Products Co,.Ltd Company Information
6.6.2 Chengdu TECH-BANK Biological Products Co,.Ltd Description and Business Overview
6.6.3 Chengdu TECH-BANK Biological Products Co,.Ltd Swine Reproductive and Respiratory Syndrome Vaccine Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Chengdu TECH-BANK Biological Products Co,.Ltd Swine Reproductive and Respiratory Syndrome Vaccine Product Portfolio
6.6.5 Chengdu TECH-BANK Biological Products Co,.Ltd Recent Developments/Updates
6.7 ringpu
6.7.1 ringpu Company Information
6.7.2 ringpu Description and Business Overview
6.7.3 ringpu Swine Reproductive and Respiratory Syndrome Vaccine Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 ringpu Swine Reproductive and Respiratory Syndrome Vaccine Product Portfolio
6.7.5 ringpu Recent Developments/Updates
6.8 QILU ANIMAL HEALTH PRODUCTS CO.,LTD
6.8.1 QILU ANIMAL HEALTH PRODUCTS CO.,LTD Company Information
6.8.2 QILU ANIMAL HEALTH PRODUCTS CO.,LTD Description and Business Overview
6.8.3 QILU ANIMAL HEALTH PRODUCTS CO.,LTD Swine Reproductive and Respiratory Syndrome Vaccine Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 QILU ANIMAL HEALTH PRODUCTS CO.,LTD Swine Reproductive and Respiratory Syndrome Vaccine Product Portfolio
6.8.5 QILU ANIMAL HEALTH PRODUCTS CO.,LTD Recent Developments/Updates
6.9 DAHUANONG
6.9.1 DAHUANONG Company Information
6.9.2 DAHUANONG Description and Business Overview
6.9.3 DAHUANONG Swine Reproductive and Respiratory Syndrome Vaccine Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 DAHUANONG Swine Reproductive and Respiratory Syndrome Vaccine Product Portfolio
6.9.5 DAHUANONG Recent Developments/Updates
6.10 CAVAC
6.10.1 CAVAC Company Information
6.10.2 CAVAC Description and Business Overview
6.10.3 CAVAC Swine Reproductive and Respiratory Syndrome Vaccine Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 CAVAC Swine Reproductive and Respiratory Syndrome Vaccine Product Portfolio
6.10.5 CAVAC Recent Developments/Updates
6.11 Komipharm
6.11.1 Komipharm Company Information
6.11.2 Komipharm Description and Business Overview
6.11.3 Komipharm Swine Reproductive and Respiratory Syndrome Vaccine Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 Komipharm Swine Reproductive and Respiratory Syndrome Vaccine Product Portfolio
6.11.5 Komipharm Recent Developments/Updates
6.12 Agrovet
6.12.1 Agrovet Company Information
6.12.2 Agrovet Description and Business Overview
6.12.3 Agrovet Swine Reproductive and Respiratory Syndrome Vaccine Sales, Revenue, and Gross Margin (2021–2026)
6.12.4 Agrovet Swine Reproductive and Respiratory Syndrome Vaccine Product Portfolio
6.12.5 Agrovet Recent Developments/Updates
6.13 Bioveta
6.13.1 Bioveta Company Information
6.13.2 Bioveta Description and Business Overview
6.13.3 Bioveta Swine Reproductive and Respiratory Syndrome Vaccine Sales, Revenue, and Gross Margin (2021–2026)
6.13.4 Bioveta Swine Reproductive and Respiratory Syndrome Vaccine Product Portfolio
6.13.5 Bioveta Recent Developments/Updates
6.14 JINYU BIO-TECNOLOGY CO.,LTD
6.14.1 JINYU BIO-TECNOLOGY CO.,LTD Company Information
6.14.2 JINYU BIO-TECNOLOGY CO.,LTD Description and Business Overview
6.14.3 JINYU BIO-TECNOLOGY CO.,LTD Swine Reproductive and Respiratory Syndrome Vaccine Sales, Revenue, and Gross Margin (2021–2026)
6.14.4 JINYU BIO-TECNOLOGY CO.,LTD Swine Reproductive and Respiratory Syndrome Vaccine Product Portfolio
6.14.5 JINYU BIO-TECNOLOGY CO.,LTD Recent Developments/Updates
6.15 Phibro Animal Health
6.15.1 Phibro Animal Health Company Information
6.15.2 Phibro Animal Health Description and Business Overview
6.15.3 Phibro Animal Health Swine Reproductive and Respiratory Syndrome Vaccine Sales, Revenue, and Gross Margin (2021–2026)
6.15.4 Phibro Animal Health Swine Reproductive and Respiratory Syndrome Vaccine Product Portfolio
6.15.5 Phibro Animal Health Recent Developments/Updates
6.16 ANHUI TIANKANG(GROUP)SHRES O., LTD
6.16.1 ANHUI TIANKANG(GROUP)SHRES O., LTD Company Information
6.16.2 ANHUI TIANKANG(GROUP)SHRES O., LTD Description and Business Overview
6.16.3 ANHUI TIANKANG(GROUP)SHRES O., LTD Swine Reproductive and Respiratory Syndrome Vaccine Sales, Revenue, and Gross Margin (2021–2026)
6.16.4 ANHUI TIANKANG(GROUP)SHRES O., LTD Swine Reproductive and Respiratory Syndrome Vaccine Product Portfolio
6.16.5 ANHUI TIANKANG(GROUP)SHRES O., LTD Recent Developments/Updates
6.17 Zoetis
6.17.1 Zoetis Company Information
6.17.2 Zoetis Description and Business Overview
6.17.3 Zoetis Swine Reproductive and Respiratory Syndrome Vaccine Sales, Revenue, and Gross Margin (2021–2026)
6.17.4 Zoetis Swine Reproductive and Respiratory Syndrome Vaccine Product Portfolio
6.17.5 Zoetis Recent Developments/Updates
6.18 WINSUN BIO
6.18.1 WINSUN BIO Company Information
6.18.2 WINSUN BIO Description and Business Overview
6.18.3 WINSUN BIO Swine Reproductive and Respiratory Syndrome Vaccine Sales, Revenue, and Gross Margin (2021–2026)
6.18.4 WINSUN BIO Swine Reproductive and Respiratory Syndrome Vaccine Product Portfolio
6.18.5 WINSUN BIO Recent Developments/Updates
6.19 PULIKE BIOLOGICAL ENGINERING,INC.
6.19.1 PULIKE BIOLOGICAL ENGINERING,INC. Company Information
6.19.2 PULIKE BIOLOGICAL ENGINERING,INC. Description and Business Overview
6.19.3 PULIKE BIOLOGICAL ENGINERING,INC. Swine Reproductive and Respiratory Syndrome Vaccine Sales, Revenue, and Gross Margin (2021–2026)
6.19.4 PULIKE BIOLOGICAL ENGINERING,INC. Swine Reproductive and Respiratory Syndrome Vaccine Product Portfolio
6.19.5 PULIKE BIOLOGICAL ENGINERING,INC. Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Swine Reproductive and Respiratory Syndrome Vaccine Industry Chain Analysis
7.2 Swine Reproductive and Respiratory Syndrome Vaccine Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Swine Reproductive and Respiratory Syndrome Vaccine Production Mode & Process Analysis
7.4 Swine Reproductive and Respiratory Syndrome Vaccine Sales and Marketing
7.4.1 Swine Reproductive and Respiratory Syndrome Vaccine Sales Channels
7.4.2 Swine Reproductive and Respiratory Syndrome Vaccine Distributors
7.5 Swine Reproductive and Respiratory Syndrome Vaccine Customer Analysis
8 Swine Reproductive and Respiratory Syndrome Vaccine Market Dynamics
8.1 Swine Reproductive and Respiratory Syndrome Vaccine Industry Trends
8.2 Swine Reproductive and Respiratory Syndrome Vaccine Market Drivers
8.3 Swine Reproductive and Respiratory Syndrome Vaccine Market Challenges
8.4 Swine Reproductive and Respiratory Syndrome Vaccine Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Swine Reproductive and Respiratory Syndrome Vaccine Market Value by Type (US$ Million), 2025 vs 2032
 Table 2. Global Swine Reproductive and Respiratory Syndrome Vaccine Market Value by Application (US$ Million), 2025 vs 2032
 Table 3. Global Swine Reproductive and Respiratory Syndrome Vaccine Market Competitive Situation by Manufacturers in 2025
 Table 4. Global Swine Reproductive and Respiratory Syndrome Vaccine Sales (K Units) of Key Manufacturers (2021–2026)
 Table 5. Global Swine Reproductive and Respiratory Syndrome Vaccine Sales Market Share by Manufacturers (2021–2026)
 Table 6. Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue (US$ Million) by Manufacturers (2021–2026)
 Table 7. Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue Share by Manufacturers (2021–2026)
 Table 8. Global Market Swine Reproductive and Respiratory Syndrome Vaccine Average Price (USD/Unit) of Key Manufacturers (2021–2026)
 Table 9. Global Key Players of Swine Reproductive and Respiratory Syndrome Vaccine, Industry Ranking, 2023 vs 2024 vs 2025
 Table 10. Global Key Manufacturers of Swine Reproductive and Respiratory Syndrome Vaccine, Manufacturing Sites and Headquarters
 Table 11. Global Key Manufacturers of Swine Reproductive and Respiratory Syndrome Vaccine, Product Types and Applications
 Table 12. Global Key Manufacturers of Swine Reproductive and Respiratory Syndrome Vaccine, Date of Entry into the Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Swine Reproductive and Respiratory Syndrome Vaccine Companies by Tier (Tier 1, Tier 2, Tier 3), based on Swine Reproductive and Respiratory Syndrome Vaccine Revenue, 2025
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Swine Reproductive and Respiratory Syndrome Vaccine Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 17. Global Swine Reproductive and Respiratory Syndrome Vaccine Sales by Region (K Units), 2021–2026
 Table 18. Global Swine Reproductive and Respiratory Syndrome Vaccine Sales Market Share by Region (2021–2026)
 Table 19. Global Swine Reproductive and Respiratory Syndrome Vaccine Sales by Region (K Units), 2027–2032
 Table 20. Global Swine Reproductive and Respiratory Syndrome Vaccine Sales Market Share by Region (2027–2032)
 Table 21. Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue by Region (US$ Million), 2021–2026
 Table 22. Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue Market Share by Region (2021–2026)
 Table 23. Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue by Region (US$ Million), 2027–2032
 Table 24. Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue Market Share by Region (2027–2032)
 Table 25. North America Swine Reproductive and Respiratory Syndrome Vaccine Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 26. North America Swine Reproductive and Respiratory Syndrome Vaccine Sales by Country (K Units), 2021–2026
 Table 27. North America Swine Reproductive and Respiratory Syndrome Vaccine Sales by Country (K Units), 2027–2032
 Table 28. North America Swine Reproductive and Respiratory Syndrome Vaccine Revenue by Country (US$ Million), 2021–2026
 Table 29. North America Swine Reproductive and Respiratory Syndrome Vaccine Revenue by Country (US$ Million), 2027–2032
 Table 30. Europe Swine Reproductive and Respiratory Syndrome Vaccine Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 31. Europe Swine Reproductive and Respiratory Syndrome Vaccine Sales by Country (K Units), 2021–2026
 Table 32. Europe Swine Reproductive and Respiratory Syndrome Vaccine Sales by Country (K Units), 2027–2032
 Table 33. Europe Swine Reproductive and Respiratory Syndrome Vaccine Revenue by Country (US$ Million), 2021–2026
 Table 34. Europe Swine Reproductive and Respiratory Syndrome Vaccine Revenue by Country (US$ Million), 2027–2032
 Table 35. Asia Pacific Swine Reproductive and Respiratory Syndrome Vaccine Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
 Table 36. Asia Pacific Swine Reproductive and Respiratory Syndrome Vaccine Sales by Region (K Units), 2021–2026
 Table 37. Asia Pacific Swine Reproductive and Respiratory Syndrome Vaccine Sales by Region (K Units), 2027–2032
 Table 38. Asia Pacific Swine Reproductive and Respiratory Syndrome Vaccine Revenue by Region (US$ Million), 2021–2026
 Table 39. Asia Pacific Swine Reproductive and Respiratory Syndrome Vaccine Revenue by Region (US$ Million), 2027–2032
 Table 40. Latin America Swine Reproductive and Respiratory Syndrome Vaccine Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 41. Latin America Swine Reproductive and Respiratory Syndrome Vaccine Sales by Country (K Units), 2021–2026
 Table 42. Latin America Swine Reproductive and Respiratory Syndrome Vaccine Sales by Country (K Units), 2027–2032
 Table 43. Latin America Swine Reproductive and Respiratory Syndrome Vaccine Revenue by Country (US$ Million), 2021–2026
 Table 44. Latin America Swine Reproductive and Respiratory Syndrome Vaccine Revenue by Country (US$ Million), 2027–2032
 Table 45. Middle East and Africa Swine Reproductive and Respiratory Syndrome Vaccine Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 46. Middle East and Africa Swine Reproductive and Respiratory Syndrome Vaccine Sales by Country (K Units), 2021–2026
 Table 47. Middle East and Africa Swine Reproductive and Respiratory Syndrome Vaccine Sales by Country (K Units), 2027–2032
 Table 48. Middle East and Africa Swine Reproductive and Respiratory Syndrome Vaccine Revenue by Country (US$ Million), 2021–2026
 Table 49. Middle East and Africa Swine Reproductive and Respiratory Syndrome Vaccine Revenue by Country (US$ Million), 2027–2032
 Table 50. Global Swine Reproductive and Respiratory Syndrome Vaccine Sales (K Units) by Type (2021–2026)
 Table 51. Global Swine Reproductive and Respiratory Syndrome Vaccine Sales (K Units) by Type (2027–2032)
 Table 52. Global Swine Reproductive and Respiratory Syndrome Vaccine Sales Market Share by Type (2021–2026)
 Table 53. Global Swine Reproductive and Respiratory Syndrome Vaccine Sales Market Share by Type (2027–2032)
 Table 54. Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue (US$ Million) by Type (2021–2026)
 Table 55. Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue (US$ Million) by Type (2027–2032)
 Table 56. Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue Market Share by Type (2021–2026)
 Table 57. Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue Market Share by Type (2027–2032)
 Table 58. Global Swine Reproductive and Respiratory Syndrome Vaccine Price (USD/Unit) by Type (2021–2026)
 Table 59. Global Swine Reproductive and Respiratory Syndrome Vaccine Price (USD/Unit) by Type (2027–2032)
 Table 60. Global Swine Reproductive and Respiratory Syndrome Vaccine Sales (K Units) by Application (2021–2026)
 Table 61. Global Swine Reproductive and Respiratory Syndrome Vaccine Sales (K Units) by Application (2027–2032)
 Table 62. Global Swine Reproductive and Respiratory Syndrome Vaccine Sales Market Share by Application (2021–2026)
 Table 63. Global Swine Reproductive and Respiratory Syndrome Vaccine Sales Market Share by Application (2027–2032)
 Table 64. Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue (US$ Million) by Application (2021–2026)
 Table 65. Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue (US$ Million) by Application (2027–2032)
 Table 66. Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue Market Share by Application (2021–2026)
 Table 67. Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue Market Share by Application (2027–2032)
 Table 68. Global Swine Reproductive and Respiratory Syndrome Vaccine Price (USD/Unit) by Application (2021–2026)
 Table 69. Global Swine Reproductive and Respiratory Syndrome Vaccine Price (USD/Unit) by Application (2027–2032)
 Table 70. ASCENT CORPORATION Company Information
 Table 71. ASCENT CORPORATION Description and Business Overview
 Table 72. ASCENT CORPORATION Swine Reproductive and Respiratory Syndrome Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 73. ASCENT CORPORATION Swine Reproductive and Respiratory Syndrome Vaccine Product
 Table 74. ASCENT CORPORATION Recent Developments/Updates
 Table 75. Boehringer-Ingelheim Company Information
 Table 76. Boehringer-Ingelheim Description and Business Overview
 Table 77. Boehringer-Ingelheim Swine Reproductive and Respiratory Syndrome Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 78. Boehringer-Ingelheim Swine Reproductive and Respiratory Syndrome Vaccine Product
 Table 79. Boehringer-Ingelheim Recent Developments/Updates
 Table 80. MSD Animal Health Company Information
 Table 81. MSD Animal Health Description and Business Overview
 Table 82. MSD Animal Health Swine Reproductive and Respiratory Syndrome Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 83. MSD Animal Health Swine Reproductive and Respiratory Syndrome Vaccine Product
 Table 84. MSD Animal Health Recent Developments/Updates
 Table 85. SPAH Company Information
 Table 86. SPAH Description and Business Overview
 Table 87. SPAH Swine Reproductive and Respiratory Syndrome Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 88. SPAH Swine Reproductive and Respiratory Syndrome Vaccine Product
 Table 89. SPAH Recent Developments/Updates
 Table 90. Ceva Company Information
 Table 91. Ceva Description and Business Overview
 Table 92. Ceva Swine Reproductive and Respiratory Syndrome Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 93. Ceva Swine Reproductive and Respiratory Syndrome Vaccine Product
 Table 94. Ceva Recent Developments/Updates
 Table 95. Chengdu TECH-BANK Biological Products Co,.Ltd Company Information
 Table 96. Chengdu TECH-BANK Biological Products Co,.Ltd Description and Business Overview
 Table 97. Chengdu TECH-BANK Biological Products Co,.Ltd Swine Reproductive and Respiratory Syndrome Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 98. Chengdu TECH-BANK Biological Products Co,.Ltd Swine Reproductive and Respiratory Syndrome Vaccine Product
 Table 99. Chengdu TECH-BANK Biological Products Co,.Ltd Recent Developments/Updates
 Table 100. ringpu Company Information
 Table 101. ringpu Description and Business Overview
 Table 102. ringpu Swine Reproductive and Respiratory Syndrome Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 103. ringpu Swine Reproductive and Respiratory Syndrome Vaccine Product
 Table 104. ringpu Recent Developments/Updates
 Table 105. QILU ANIMAL HEALTH PRODUCTS CO.,LTD Company Information
 Table 106. QILU ANIMAL HEALTH PRODUCTS CO.,LTD Description and Business Overview
 Table 107. QILU ANIMAL HEALTH PRODUCTS CO.,LTD Swine Reproductive and Respiratory Syndrome Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 108. QILU ANIMAL HEALTH PRODUCTS CO.,LTD Swine Reproductive and Respiratory Syndrome Vaccine Product
 Table 109. QILU ANIMAL HEALTH PRODUCTS CO.,LTD Recent Developments/Updates
 Table 110. DAHUANONG Company Information
 Table 111. DAHUANONG Description and Business Overview
 Table 112. DAHUANONG Swine Reproductive and Respiratory Syndrome Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 113. DAHUANONG Swine Reproductive and Respiratory Syndrome Vaccine Product
 Table 114. DAHUANONG Recent Developments/Updates
 Table 115. CAVAC Company Information
 Table 116. CAVAC Description and Business Overview
 Table 117. CAVAC Swine Reproductive and Respiratory Syndrome Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 118. CAVAC Swine Reproductive and Respiratory Syndrome Vaccine Product
 Table 119. CAVAC Recent Developments/Updates
 Table 120. Komipharm Company Information
 Table 121. Komipharm Description and Business Overview
 Table 122. Komipharm Swine Reproductive and Respiratory Syndrome Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 123. Komipharm Swine Reproductive and Respiratory Syndrome Vaccine Product
 Table 124. Komipharm Recent Developments/Updates
 Table 125. Agrovet Company Information
 Table 126. Agrovet Description and Business Overview
 Table 127. Agrovet Swine Reproductive and Respiratory Syndrome Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 128. Agrovet Swine Reproductive and Respiratory Syndrome Vaccine Product
 Table 129. Agrovet Recent Developments/Updates
 Table 130. Bioveta Company Information
 Table 131. Bioveta Description and Business Overview
 Table 132. Bioveta Swine Reproductive and Respiratory Syndrome Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 133. Bioveta Swine Reproductive and Respiratory Syndrome Vaccine Product
 Table 134. Bioveta Recent Developments/Updates
 Table 135. JINYU BIO-TECNOLOGY CO.,LTD Company Information
 Table 136. JINYU BIO-TECNOLOGY CO.,LTD Description and Business Overview
 Table 137. JINYU BIO-TECNOLOGY CO.,LTD Swine Reproductive and Respiratory Syndrome Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 138. JINYU BIO-TECNOLOGY CO.,LTD Swine Reproductive and Respiratory Syndrome Vaccine Product
 Table 139. JINYU BIO-TECNOLOGY CO.,LTD Recent Developments/Updates
 Table 140. Phibro Animal Health Company Information
 Table 141. Phibro Animal Health Description and Business Overview
 Table 142. Phibro Animal Health Swine Reproductive and Respiratory Syndrome Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 143. Phibro Animal Health Swine Reproductive and Respiratory Syndrome Vaccine Product
 Table 144. Phibro Animal Health Recent Developments/Updates
 Table 145. ANHUI TIANKANG(GROUP)SHRES O., LTD Company Information
 Table 146. ANHUI TIANKANG(GROUP)SHRES O., LTD Description and Business Overview
 Table 147. ANHUI TIANKANG(GROUP)SHRES O., LTD Swine Reproductive and Respiratory Syndrome Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 148. ANHUI TIANKANG(GROUP)SHRES O., LTD Swine Reproductive and Respiratory Syndrome Vaccine Product
 Table 149. ANHUI TIANKANG(GROUP)SHRES O., LTD Recent Developments/Updates
 Table 150. Zoetis Company Information
 Table 151. Zoetis Description and Business Overview
 Table 152. Zoetis Swine Reproductive and Respiratory Syndrome Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 153. Zoetis Swine Reproductive and Respiratory Syndrome Vaccine Product
 Table 154. Zoetis Recent Developments/Updates
 Table 155. WINSUN BIO Company Information
 Table 156. WINSUN BIO Description and Business Overview
 Table 157. WINSUN BIO Swine Reproductive and Respiratory Syndrome Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 158. WINSUN BIO Swine Reproductive and Respiratory Syndrome Vaccine Product
 Table 159. WINSUN BIO Recent Developments/Updates
 Table 160. PULIKE BIOLOGICAL ENGINERING,INC. Company Information
 Table 161. PULIKE BIOLOGICAL ENGINERING,INC. Description and Business Overview
 Table 162. PULIKE BIOLOGICAL ENGINERING,INC. Swine Reproductive and Respiratory Syndrome Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 163. PULIKE BIOLOGICAL ENGINERING,INC. Swine Reproductive and Respiratory Syndrome Vaccine Product
 Table 164. PULIKE BIOLOGICAL ENGINERING,INC. Recent Developments/Updates
 Table 165. Key Raw Materials Lists
 Table 166. Raw Materials Key Suppliers Lists
 Table 167. Swine Reproductive and Respiratory Syndrome Vaccine Distributors List
 Table 168. Swine Reproductive and Respiratory Syndrome Vaccine Customers List
 Table 169. Swine Reproductive and Respiratory Syndrome Vaccine Market Trends
 Table 170. Swine Reproductive and Respiratory Syndrome Vaccine Market Drivers
 Table 171. Swine Reproductive and Respiratory Syndrome Vaccine Market Challenges
 Table 172. Swine Reproductive and Respiratory Syndrome Vaccine Market Restraints
 Table 173. Research Programs/Design for This Report
 Table 174. Key Data Information from Secondary Sources
 Table 175. Key Data Information from Primary Sources
 Table 176. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Swine Reproductive and Respiratory Syndrome Vaccine
 Figure 2. Global Swine Reproductive and Respiratory Syndrome Vaccine Market Value by Type (US$ Million), 2021–2032
 Figure 3. Global Swine Reproductive and Respiratory Syndrome Vaccine Market Share by Type: 2025 & 2032
 Figure 4. Active Vaccine Product Picture
 Figure 5. Inactivated Vaccines Product Picture
 Figure 6. Global Swine Reproductive and Respiratory Syndrome Vaccine Market Value by Application (US$ Million), 2021–2032
 Figure 7. Global Swine Reproductive and Respiratory Syndrome Vaccine Market Share by Application: 2025 & 2032
 Figure 8. Government Tender
 Figure 9. Market Sales
 Figure 10. Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue, (US$ Million), 2021 vs 2025 vs 2032
 Figure 11. Global Swine Reproductive and Respiratory Syndrome Vaccine Market Size (US$ Million), 2021–2032
 Figure 12. Global Swine Reproductive and Respiratory Syndrome Vaccine Sales (K Units), 2021–2032
 Figure 13. Global Swine Reproductive and Respiratory Syndrome Vaccine Average Price (USD/Unit), 2021–2032
 Figure 14. Swine Reproductive and Respiratory Syndrome Vaccine Report Years Considered
 Figure 15. Swine Reproductive and Respiratory Syndrome Vaccine Sales Share by Manufacturers in 2025
 Figure 16. Global Swine Reproductive and Respiratory Syndrome Vaccine Revenue Share by Manufacturers in 2025
 Figure 17. Top 5 and Top 10 Global Swine Reproductive and Respiratory Syndrome Vaccine Players: Market Share by Revenue in Swine Reproductive and Respiratory Syndrome Vaccine in 2025
 Figure 18. Swine Reproductive and Respiratory Syndrome Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
 Figure 19. Global Swine Reproductive and Respiratory Syndrome Vaccine Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Figure 20. North America Swine Reproductive and Respiratory Syndrome Vaccine Sales Market Share by Country (2021–2032)
 Figure 21. North America Swine Reproductive and Respiratory Syndrome Vaccine Revenue Market Share by Country (2021–2032)
 Figure 22. U.S. Swine Reproductive and Respiratory Syndrome Vaccine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 23. Canada Swine Reproductive and Respiratory Syndrome Vaccine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 24. Europe Swine Reproductive and Respiratory Syndrome Vaccine Sales Market Share by Country (2021–2032)
 Figure 25. Europe Swine Reproductive and Respiratory Syndrome Vaccine Revenue Market Share by Country (2021–2032)
 Figure 26. Germany Swine Reproductive and Respiratory Syndrome Vaccine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 27. France Swine Reproductive and Respiratory Syndrome Vaccine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 28. U.K. Swine Reproductive and Respiratory Syndrome Vaccine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 29. Italy Swine Reproductive and Respiratory Syndrome Vaccine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 30. Russia Swine Reproductive and Respiratory Syndrome Vaccine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 31. Asia Pacific Swine Reproductive and Respiratory Syndrome Vaccine Sales Market Share by Region (2021–2032)
 Figure 32. Asia Pacific Swine Reproductive and Respiratory Syndrome Vaccine Revenue Market Share by Region (2021–2032)
 Figure 33. China Swine Reproductive and Respiratory Syndrome Vaccine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 34. Japan Swine Reproductive and Respiratory Syndrome Vaccine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 35. South Korea Swine Reproductive and Respiratory Syndrome Vaccine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 36. India Swine Reproductive and Respiratory Syndrome Vaccine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 37. Australia Swine Reproductive and Respiratory Syndrome Vaccine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 38. Taiwan Swine Reproductive and Respiratory Syndrome Vaccine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 39. Indonesia Swine Reproductive and Respiratory Syndrome Vaccine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 40. Thailand Swine Reproductive and Respiratory Syndrome Vaccine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 41. Malaysia Swine Reproductive and Respiratory Syndrome Vaccine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 42. Philippines Swine Reproductive and Respiratory Syndrome Vaccine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 43. Latin America Swine Reproductive and Respiratory Syndrome Vaccine Sales Market Share by Country (2021–2032)
 Figure 44. Latin America Swine Reproductive and Respiratory Syndrome Vaccine Revenue Market Share by Country (2021–2032)
 Figure 45. Mexico Swine Reproductive and Respiratory Syndrome Vaccine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 46. Brazil Swine Reproductive and Respiratory Syndrome Vaccine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 47. Argentina Swine Reproductive and Respiratory Syndrome Vaccine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 48. Middle East and Africa Swine Reproductive and Respiratory Syndrome Vaccine Sales Market Share by Country (2021–2032)
 Figure 49. Middle East and Africa Swine Reproductive and Respiratory Syndrome Vaccine Revenue Market Share by Country (2021–2032)
 Figure 50. Turkey Swine Reproductive and Respiratory Syndrome Vaccine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 51. Saudi Arabia Swine Reproductive and Respiratory Syndrome Vaccine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 52. UAE Swine Reproductive and Respiratory Syndrome Vaccine Revenue Growth Rate (US$ Million), 2021–2032
 Figure 53. Global Sales Market Share of Swine Reproductive and Respiratory Syndrome Vaccine by Type (2021–2032)
 Figure 54. Global Revenue Market Share of Swine Reproductive and Respiratory Syndrome Vaccine by Type (2021–2032)
 Figure 55. Global Swine Reproductive and Respiratory Syndrome Vaccine Price (USD/Unit) by Type (2021–2032)
 Figure 56. Global Sales Market Share of Swine Reproductive and Respiratory Syndrome Vaccine by Application (2021–2032)
 Figure 57. Global Revenue Market Share of Swine Reproductive and Respiratory Syndrome Vaccine by Application (2021–2032)
 Figure 58. Global Swine Reproductive and Respiratory Syndrome Vaccine Price (USD/Unit) by Application (2021–2032)
 Figure 59. Swine Reproductive and Respiratory Syndrome Vaccine Value Chain
 Figure 60. Channels of Distribution (Direct Vs Distribution)
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Lukasiewicz Research Network

SIMILAR REPORTS